Cite
HARVARD Citation
Robak, P. et al. (2023). Immunotherapy combinations for chronic lymphocytic leukemia: advantages and disadvantages. Expert opinion on biological therapy. pp. 21-35. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Robak, P. et al. (2023). Immunotherapy combinations for chronic lymphocytic leukemia: advantages and disadvantages. Expert opinion on biological therapy. pp. 21-35. [Online].